ScreenerHero
ALECREurofins-Cerep SA
EPA · FR · Healthcare · Diagnostics & Research · eurofins.fr
16300.00EUR0.00%Mkt Cap: 89.37M $P/E: 17.18

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound man…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap89.37M $
Enterprise Value—
Revenue (TTM)44.67M $
Gross Profit23.83M $
Net Income (TTM)5.20M $
Revenue/Share—
Last Price16300.00 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)17.18
P/E (Forward)—
PEG3.26
EV/EBITDA—
EV/Revenue—
P/S2.00
P/B—
EPS (TTM)948.66
EPS (Forward)—
52W Range
15300.0030% of range18600.00
52W High18600.00 EUR
52W Low15300.00 EUR
Profitability
Gross Margin53.49%
Oper. Margin10.17%
EBITDA Margin13.94%
Profit Margin11.67%
ROE6.25%
ROA5.37%
Growth
Revenue Growth10.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-22.86M $
Net Debt/EBITDA-3.67
Balance Sheet
Debt/Equity0.00
Current Ratio7.83
Quick Ratio7.53
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateJul 27, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.04K
Float—
Insiders95.78%
Institutions0.00%
Technical
SMA 5016254.00 (+0.3%)
SMA 20016491.00 (-1.2%)
Beta0.01
S&P 52W Chg18.16%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)49.2
MACD-2.8855
MACD Signal2.2127
MACD Hist.-5.0983
BB Upper16300.00 EUR
BB Middle16300.00 EUR
BB Lower16300.00 EUR
BB Width0.00%
ATR (14)30.61 EUR
Vol Ratio (20d)—